Trials / Conditions / Large B-Cell Lymphoma With IRF4 Rearrangement
Large B-Cell Lymphoma With IRF4 Rearrangement
3 registered clinical trials studyying Large B-Cell Lymphoma With IRF4 Rearrangement — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphom NCT06834373 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin NCT05202782 | Northwestern University | Phase 2 |
| Active Not Recruiting | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho NCT03038672 | National Cancer Institute (NCI) | Phase 2 |